# REGENXBIO Inc. (RGNX) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from REGENXBIO Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/RGNX/mda/fy2025/): filed 2026-03-05; accession 0001193125-26-094013 (https://www.sec.gov/Archives/edgar/data/1590877/000119312526094013/rgnx-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/RGNX/mda/fy2024/): filed 2025-03-13; accession 0000950170-25-038770 (https://www.sec.gov/Archives/edgar/data/1590877/000095017025038770/rgnx-20241231.htm)
- [FY 2023 MD&A](/company/RGNX/mda/fy2023/): filed 2024-02-27; accession 0000950170-24-021161 (https://www.sec.gov/Archives/edgar/data/1590877/000095017024021161/rgnx-20231231.htm)
- [FY 2022 MD&A](/company/RGNX/mda/fy2022/): filed 2023-02-28; accession 0000950170-23-005085 (https://www.sec.gov/Archives/edgar/data/1590877/000095017023005085/rgnx-20221231.htm)
- [FY 2021 MD&A](/company/RGNX/mda/fy2021/): filed 2022-03-01; accession 0001564590-22-008055 (https://www.sec.gov/Archives/edgar/data/1590877/000156459022008055/rgnx-10k_20211231.htm)

Back to /company/RGNX/